FranΓ§aisπ See the interactive version (live chart) β
For Keurig Dr Pepper, we replayed every analyst price target of the past 12 months and measured the real outcome: 13% were profitable, average return -2% (84 calls). At 3 months: +0% average return (31% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Barclays | 23 | 13% | -2% |
| JP Morgan | 9 | 0% | -8% |
| Wells Fargo | 7 | 0% | -11% |
| RBC Capital | 7 | 14% | -3% |
| UBS | 6 | 0% | -6% |
Is Keurig Dr Pepper overvalued, and is it a good time to buy Keurig Dr Pepper right now? If you're wondering, here's a recap to make up your own mind: Keurig Dr Pepper's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Keurig Dr Pepper | Sector median (Consumer Staples) |
|---|---|---|
| P/E | 32.5 | 24.4 |
| Forward P/E | 12.6 | 15.6 |
| Net margin | 7% | 7% |
π Keurig Dr Pepper trades above its sector median (32.5 vs 24.4) β the market expects higher growth; watch out for disappointment.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : Keurig Dr Pepper pays about $0.92/share/yr β 2.76% yield. what is this?
The analyst consensus on Keurig Dr Pepper (KDP) is "Buy" (23 bullish, 1 bearish calls over 12 months). This is not advice: historically, 13% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $37.50 (+18% vs $31.88), ranging from $28.00 to $40.00 (10 analysts).
Over 1 year, 13% of analyst targets on Keurig Dr Pepper were profitable, for an average return of -2% (across 84 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $37.50 within 12 months, i.e. +18% vs the current price. The most bullish targets $40.00, the most cautious $28.00.
Note: analyst targets are 12-month (median $37.50, +18%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (13%), and the stock's past trajectory.
Its P/E is 32.5, forward P/E 12.6. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Keurig Dr Pepper β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.